CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle...

15
1 CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of Anaesthesiology, Pharmacology and Intensive care University Hospitals of Geneva Rue Gabrielle-Perret-Gentil 4 1211 Geneva 14 Tel: +41 (0)22.382.99.34 / +41 (0)79.553.22.18 E-mail: [email protected] Languages English: mother tongue French: mother tongue German: good knowledge Italian: good knowledge 2. PRESENT POSITION Since 2004 Adjunct Pharmacist, Division of Clinical Pharmacology and Toxicology, Department of Anaesthesiology, Pharmacology and Intensive care (Prof Jules Desmeules). Since 2013 Adjunct Pharmacist, Clinical Trial Unit, Medical Directorate (Prof. Arnaud Perrier/Prof Jules Desmeules).

Transcript of CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle...

Page 1: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

1

CURRICULUM VITAE

1. PERSONAL DATA

Surname: Rollason

Name: Victoria Michèle

Professional address: Division of Clinical Pharmacology and Toxicology

Department of Anaesthesiology, Pharmacology and Intensive care

University Hospitals of Geneva

Rue Gabrielle-Perret-Gentil 4

1211 Geneva 14

Tel: +41 (0)22.382.99.34 / +41 (0)79.553.22.18

E-mail: [email protected]

Languages English: mother tongue

French: mother tongue

German: good knowledge

Italian: good knowledge

2. PRESENT POSITION

Since 2004 Adjunct Pharmacist, Division of Clinical Pharmacology and Toxicology, Department of

Anaesthesiology, Pharmacology and Intensive care (Prof Jules Desmeules).

Since 2013 Adjunct Pharmacist, Clinical Trial Unit, Medical Directorate (Prof. Arnaud Perrier/Prof Jules

Desmeules).

Page 2: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

2

3. DIPLOMAS

2015 Certificate in Pharmacoepidemiology and Pharmacovigilance, London School of Hygiene and Tropical Medicine, London, UK.

2004 Clinical Pharmacologist SGKPT/SSPTC, Swiss Society of Clinical Pharmacology and Toxicology.

2003 Doctor of Pharmaceutical Sciences, Thesis No 3473, "Pain in the elderly - An updated review of

current research and therapeutic practice, Future perspectives suggested by novel experiments with tramadol”, University of Geneva, Geneva, Switzerland.

1992 Degree in pharmacy (diploma), Department of Sciences, University of Geneva, Geneva,

Switzerland.

1987 Swiss Maturité type B, Latin section, Collège de Sismondi, Geneva, Switzerland.

4. OTHER TRAINING AND EDUCATION

2014 Les fondamentaux de la stratégie des gains mutuels, centre de formation HUG, Geneva, Switzerland.

2014 Secutrial, Geneva, Switzerland.

2014 Coding with MedDRA, Bern, Switzerland.

2014 Latest update on Human Research Act (HRA) - Impact on regulation of clinical trials in

Switzerland, Workshop, Bern, Switzerland.

2013 Dealing with Difficult Pain Syndromes - Persistent Pain after Surgery, EFIC Refresher course, 8th

Congress of the European Federation of IASP Chapters (EFIC), Florence, Italy.

2013 Clinical therapeutics mechanism-based pharmacological pain treatment. EFIC Refresher course, 8th Congress of the European Federation of IASP Chapters (EFIC), Florence, Italy.

2013 Adverse drug reactions: clinical approach and differential diagnosis as the basis of case quality,

ISoP, Pisa, Italy.

2013 3rd Annual Pharmacovigilance SMi meeting, SMi, London, UK.

2013 Good governance in (clinical) research with human data and tissue, 4th Symposium of the Swiss

Clinical Trial Organisation, Geneva, Switzerland.

2013 Thèmes de pharmacologie et de toxicologie cliniques, Master of Advanced Studies (MAS) in Hospital Pharmacy, Geneva-Lausanne School of Pharmacy, Geneva, Switzerland.

2013 System and site inspections - practical examples, Swissmedic Workshop on GCP Inspections, Bern,

Switzerland.

2013 Assuring best practice in signal detection and management for GVP, SMi, London, UK.

2013 Clinical Pharmacology Curriculum Review Course, Clinical track. American Society of Clinical

Pharmacology and Therapeutics (ASCPT), Indianapolis, USA.

Page 3: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

3

2012 Benefit-risk assessment for the new PSUR, SMi, London, UK.

2009 International Society of Drug Bulletins: pharmacovigilance workshop and committee meeting, Bielefeld.

2005 Pharmacovigilance - Principles and practice, European Association of Clinical Pharmacology and

Therapeutics (EACPT) / EMEA / ISOP, Stockholm, Sweden.

2002 Séminaire pratique de pharmacocinétique les doigts sur le clavier, Séminaire Vaud-Genève de

formation post-graduée et continue en pharmacologie clinique, Begnins, Switzerland.

2001 Le développement du médicament, Séminaire de formation post-grade et continu, University Hospitals of Geneva, Geneva, Switzerland

2001 Le protocole de recherche clinique, Séminaire de formation post-grade et continu, University

Hospitals of Geneva, Geneva, Switzerland.

2001 Analyse statistique des données, niveau 2, Centre de formation HUG, Geneva, Switzerland.

2001 One-week Workshop in Basic Pharmacokinetics, University of Manchester, Prof Rowland, Arosa,

Switzerland.

2001 Analyse statistique des données, niveau 1, Centre de formation HUG, Geneva, Switzerland.

2000 Basic Training in Pharmacovigilance, European Society of Pharmacovigilance (ESOP), Verona, Italy.

1999 Writing and publishing in the Sciences, Centre for the Study and Teaching of Writing, McGill University, Geneva, Switzerland.

1999 Writing systematic reviews in pain, IASP, Special Interest Group for Systematic Reviews, Oxford,

UK.

5. PROFESSIONNAL ACTIVITIES

Since 2013 - Clinical Pharmacologist / Adjunct pharmacist, Division of Clinical Pharmacology and

Toxicology, University Hospitals of Geneva, Geneva.

In charge of safety management in clinical trials, creation and management of DSMBs

and management of medication of clinical studies.

Since 2004 - Clinical Pharmacologist / Adjunct pharmacist, Division of Clinical Pharmacology and

Toxicology, University Hospitals of Geneva, Geneva.

In charge of the regional pharmacovigilance centre of Geneva.

Jan 2003 - Oct 2004 Clinical Pharmacologist, Division of Clinical Pharmacology and Toxicology, University

Hospitals of Geneva, Geneva.

Page 4: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

4

Oct 2000 - Dec 2002 Research assistant, Division of Clinical Pharmacology and Toxicology, University

Hospitals of Geneva, Geneva.

Mar 1999 - Oct 2000 Research assistant, Gerontopharmacology unit, Department of Geriatrics, University

Hospitals of Geneva, Geneva.

Jan 1993 - Feb 1999 Pharmacist, Pharmacie Principale, Balexert branch, Geneva.

6. TEACHING (HOURS PER AN)

Pregraduate

Geneva-Lausanne School of Pharmacy (EPGL)

Since 2014 Courses of Clinical Pharmacology for students in 3rd

grade (last year of Bachelor), Geneva-

Lausanne School of Pharmacy, Faculty of Sciences, University of Geneva, "Module

Pharmacologie et toxicologie cliniques", 23H001.

"Pharmacologie sociale 2: Le pharmacien et les sources d'information", 2 hours.

"Pharmacologie et sécurité du médicament: Médicaments et grossesse", 2 hours.

"Pharmacologie et sécurité du médicament: Médicaments et allaitement", 2 hours.

Since 2009 Courses of Clinical Pharmacology for students in 4th

grade (1st

year of Master), Geneva-

Lausanne School of Pharmacy, Faculty of Sciences, University of Geneva, "Module

Medicaments et Maladie", 14H003.

"La bronchopneumopathie chronique obstructive (BPCO)", 2 hours.

"Les syndromes médicamenteux", 1 hour.

Faculty of medicine / Section of dental medicine

Since 2014 Courses of Clinical Pharmacology to the students in 5th

grade (last year of Master), Section of

Dental medicine, Faculty of Medicine, University of Geneva

"Ostéonecroses de la mâchoire sous bisphosphonates", 1 hour.

"Pharmacologie générale", 2 hours.

Post-graduate and continuing education

Since 2015 Scientific seminar of the Division of Clinical Pharmacology and Toxicology, "Vigilyze: de la

théorie à la pratique", University Hospitals of Geneva, Geneva, 1 hour.

Page 5: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

5

Since 2014 Scientific seminar of the Division of Clinical Pharmacology and Toxicology, "Le signal en

pharmacovigilance: qu'est-ce que c'est exactement?", University Hospitals of Geneva,

Geneva, 1 hour.

Since 2013 Programme de formation de base obligatoire des médecins nouvellement engagés aux

Hôpitaux Universitaires de Genève, "Risque nosocomial médicamenteux -

Pharmacovigilance", University Hospitals of Geneva, Geneva, 2 hours.

2013 EFIC Refresher course "Pharmacogenetics of analgesics for the non-expert". 8th

Congress of

the European Federation of IASP Chapters (EFIC), Florence, Italy, 2 hours.

2013 Master of advanced studies (MAS) in hospital pharmacy. Seminar "Thèmes de pharmacologie

et de toxicologie cliniques", "Actualité de pharmacovigilance: les nouveaux anticoagulants

oraux (NACO)", Geneva-Lausanne School of Pharmacy, University of Geneva, Geneva, 1 hour.

Since 2012 Diploma of Advanced Studies (DAS) - Management of Clinical Trials, Module 3, "Safety

Management and Drug Development", University of Geneva – University Hospitals of Geneva,

Geneva, 5 hours.

2012 Integration seminar for quality officers, "Les vigilances: pharmacovigilance", University

Hospitals of Geneva, Bossey, 1 hour.

2012 Certificate of Advanced Studies (CAS) - Management of Clinical Trials, Module 5, "Safety

Management", University de Geneva - University Hospitals of Geneva, Geneva, 3 hours.

Since 2011 Master of Advanced Studies in Toxicology (MAS), "Pharmacovigilance in clinical studies"",

University of Geneva - University Hospitals of Geneva, Geneva, 4 hours.

Since 2011 Seminar "Bonnes pratiques des études cliniques", "Session interactive: possibilités

d’événements indésirables: comment les reconnaître et les déclarer ?", University Hospitals of

Geneva - Faculty of Medicine, Geneva, 2 hours.

Since 2011 Formation des cadres aux compétences en management "Gérer les incidents en milieu

hospitalier ", "Pharmacovigilance", University Hospitals of Geneva, Geneva, 1 hour.

2010 Annual Congress of the Swiss Society of Intensive Care Medicine, Workshop: "Updates in

pharmacovigilance", Lausanne, 4 hours.

2010 Master in Advanced Sciences (MAS) in hospital pharmacy. Seminar "Thèmes de

pharmacologie et de toxicologie cliniques", "Pharmacovigilance et OTC. L'exemple des

inhibiteurs de la pompe à protons (IPP) et de l'orlistat". Geneva-Lausanne School of

Pharmacy, University of Geneva, Geneva, 1 hour.

2009 Scientific seminar of the Division of Clinical Pharmacology and Toxicoloy, University Hospitals

of Geneva, "Impact de la dioxine sur la santé humaine", Geneva, 1 hour.

Page 6: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

6

2007 Eudipharm seminar on Evaluation and use of medicinal products during pregnancy - 2nd

Edition, "Pregnancy surveillance in Geneva: from 1994 to today", Eudipharm, University

Hospitals of Geneva, Geneva, 2 hours.

2007 Scientific seminar of the Division of Clinical Pharmacology and Toxicology, University Hospitals

of Geneva, "Suivi de grossesse: de 1994 à aujourd'hui", Geneva, 1 hour.

2007 Formation des groupes de recueil et d’analyse des incidents, "Pharmacovigilance", University

Hospitals of Geneva, Geneva, 1 hour.

2007 Physicians of the Hôpital de la Tour, "Le placebo et l’effet placebo", Hôpital de la Tour,

Geneva, 1 hour.

Since 2006 Scientific seminar of the Division of Clinical Pharmacology and Toxicology, University Hospitals

of Geneva, "La pharmacovigilance", Geneva, 2 hours.

Since 2006 Scientific seminar of the Division of Clinical Pharmacology and Toxicology, University Hospitals

of Geneva, "Pharmacovigilance: utilisation de Vigiflow", Geneva, 2 hours.

2006 Diplôme d’Etudes Supérieures Spécialisées (DESS) in hospital pharmacy. Seminar "Thèmes de

pharmacologie et de toxicologie cliniques", "Médicaments, grossesse et allaitement", Geneva-

Lausanne School of Pharmacy, University of Geneva, Geneva, 1 hour.

Para-medical

2015 Course to diplomed nutritionists and dieteticien. "Nutrition et polyarthrites rhumatoïdes.

Médication et effets secondaires", HEIG-VD, Yverdon, 1 hour.

Since 2012 Courses to the students in midwifery, Bachelor 3rd

year, "Prescription et utilisation de

medicaments par la sage-femme", HEDS, Geneva, 3 hours.

Since 2012 Courses to the students in midwifery, Bachelor 1st

year, "Médicaments et allaitement", HEDS,

Geneva, 2 hours.

2010-2011 Courses to the nurse students, preparatory year, "Pharmacologie: antalgie et sédation",

HEDS, Geneva, 3 hours.

2007 Course to the "garçons de pharmacie", "Le placebo et l’effet placebo", Pharmacy of the

Univeristy Hospitals of Geneva, Geneva, 1 hour.

Since 2006 Courses to the students in nutrition and dietetics. Bachelor 3rd

year. "Module: se nourrir et se

soigner autrement", "Le placebo et l’effet placebo", HEDS, Geneva, 2 hours.

2004 Course to the assistants in pharmacy of the University Hospitals of Geneva. "Particularités de

la prescription gériatrique", Pharmacy of the University Hospitals of Geneva, Geneva, 1 hour.

Page 7: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

7

2001 Course to the students training as medical assistants. "Recherche et Qualité de l'Information

scientifique". Centre d’enseignement de Professions de la Santé et de la Petite Enfance,

Geneva, 6 hours.

2000-2001 Course to the students training as medical secretaries, "Pharmacologie générale", Ecole BER,

Geneva, 4 hours.

1999-2001 Courses to the students in physiotherapy. "Recherche et Qualité de l'Information

scientifique", HEDS, Geneva, 6 hours.

7. ADMINISTRATION / FONCTIONS OFFICIELLES

Since 2016 Treasurer of the Swiss Society of Clinical Pharmacology and Toxicology (SSPTC).

Since 2015 Member of the board of the Swiss Society of Clinical Pharmacology and Toxicology (SSPTC).

Since 2015 Vice-president of the Swiss-Austria Chapter of the International Society of Pharmacovigilance

(ISOP)

Since 2008 Member of the multidisciplinary working group "Extravasation".

Since 2006 Representative of the Division of Clinical Pharmacology and Toxicology at multi-year

pharmacovigilance meetings and other ad hoc meetings on pharmacovigilance, Swissmedic,

Bern.

2009 Member of the multidisciplinary working group "Acenocoumarol in geriatrics".

2009 Member of the multidisciplinary working group "Principes pour la préparation et

l’administration de médicaments".

Since 2005 Member of the multidisciplinary working group "Extravasation of cytostatiques".

8. DISTINCTIONS

Sytematic Review Prize 2007, IADR Evidence Based Dentistry Network, for the systematic review protocol:

"Interventions for treating osteonecrosis of the jaw bones associated with bisphosphonates".

Page 8: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

8

9. SOCIETES

Société Suisse de Pharmacologie et de Toxicologie Clinique (SSPTC), 2004 - .

International Society of Pharmacovigilance (ISOP), 2013 –

Swiss Association of Pharmaceutical Professionals (SwAPP), 2014 -

Société Suisse des pharmaciens Pharmasuisse, 2014 –

Association suisse des pharmaciens de l'administration et des hôpitaux (GSASA), 2014 –

European Society of Clinical Pharmacy (ESCP), 2014-

10. SCIENTIFIC ROLES

Reviewer

Drugs Aging

Pharmacogenomics

Personalized Medicine

Journal of Drug Delivery

11. GRANTS

Projet recherché et développement n° 19-2014-II (50'000 CHF), University Hospitals of Geneva, Geneva,

Switzerland. Observational Study to Evaluate the Impact of the CYP3A4/5 and P-gp Pharmacogenetics and

Phenotypic Activity on the Safety of Rivaroxaban in Routine Clinical Practice. Bavamian S, Rollason V, Daali Y,

Fontana P, de Moerloose P, Boehlen F, Reny JL, Rebsamen M, Combescure C, Desmeules J.

12. PATENTS

"Combined use of oral anticoagulants and related methods". P1577EP00

Page 9: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

9

13. THESIS DIRECTOR

PhD in science (section pharmacy)

2012

Mrs Liliane Gschwind, "Anticoagulation par antivitamines K: analyse des interactions médicamenteuses et des

polymorphismes génétiques à l’origine de la variabilité de la réponse et des risques liés à l’acénocoumarol".

Thèse No 28993. University of Geneva.

Diploma of Master of Advanced Studies (MAS) in hospital pharmacy

2010

Mrs Claudia Zaugg, "Evaluation et optimisation du Therapeutic Drug Monitoring en néonatologie", Geneva-

Lausanne School of Pharmacy, University of Geneva and Lausanne.

2009

Mrs Liliane Gschwind, "Etat des lieux et amélioration de la prescription de l’acénocoumarol" Geneva-Lausanne

School of Pharmacy, University of Geneva and Lausanne.

Master thesis in Pharmacy

2016

Mrs Sabrina Boumaiza, "Analyse rétrospective de l’issue d’expositions à des médicaments lors de la grossesse

signalées au service de pharmacologie et toxicologie cliniques des hôpitaux universitaires de Genève de 2004 à

2015".

Mrs Camille Lenoir, " Les inhibiteurs de la pompe à protons : sur-utilisation, effets indésirables et interactions

au travers de trois études cliniques".

Mrs Nour Khatteche, "Contribution à l’étude critique des rapports de cas publiés de nécrose de la

mâchoire induite par les bisphosphonates"

2015

Mr Malek Ben Mansour, "Chronopharmacology and risk of interaction between clopidogrel and omeprazole in

hospitalised patients", Geneva-Lausanne School of Pharmacy, University of Geneva and Lausanne.

2014

Mrs Rita Benkirane. "Etude de corrélation des phénotypes et génotypes dans une cohorte de patients

anticoagulés par antivitamine K : Evaluation du rôle des interactions médicamenteuses de l’impact des

inhibiteurs de la pompe à protons sur l’anticoagulation et le risque de saignement", Geneva-Lausanne School of

Pharmacy, University of Geneva and Lausanne.

Mrs Liene Adlere. "Snapshot of prescribing practice for clopidogrel and esomeprazole co-prescription and a

cost evaluation of guidelines application". Geneva-Lausanne School of Pharmacy, University of Geneva and

Lausanne.

Page 10: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

10

2013

Mrs Sara Oualidi. "Importance du suivi dans l’évaluation du risque des grossesses exposées aux médicaments".

Geneva-Lausanne School of Pharmacy, University of Geneva and Lausanne.

Thesis work for the Diploma of Advanced Studies (DAS) in Clinical Trials Management

2016

Mrs Giovanna Zacchetti, "Protocol Analysis and Elaboration of Documentation of Two Observational Studies on

Antithrombotic Drugs for Submission to the Ethic Committee".

Mrs Virginie Licker, "New ICH E2B (R3) message for electronic transmission of ICSR: major challenges of implementation in Europe".

2015

Mrs Sabine Bavamian, "Active surveillance of the adverse effects new oral anticoagulants in a hospital setting: a

protocol". University of Geneva.

Mrs Alexandra Laverrière, "Bonnes pratiques de pharmacovigilance: politique des éditeurs dans le cadre de la

publication de case reports". University of Geneva.

Mrs Ursula Loizides, "Trial Master File structure and organisation for the Phase 3 and 2 studies of moxidectin in

Africa sponsored by WHO". University of Geneva.

2014

Mrs Shirin Pour Nourmohammadi, February 2014, "Clinical trials and data safety monitoring boards (DSMB),

review of a year of protocols submitted to the HUG central ethics committee", University de Geneva.

Mrs Shalini Jayasekar, "The new pharmacovigilance legislation. Consequences for the Industry, the Clinical

Trials Centers and the Ethics Committees", University de Geneva.

Mr Alain Matthey, " Submission to the Swiss regulatory authorities (Swissmedic) of a category C publicly funded

clinical trial entitled: Exploring the role of the GABAergic modulation in pain transmission in human: Effect of

the GABAA agonist clobazam and N-desmethylclobazam on central sensitization: a pharmacodynamic and

pharmacokinetic study in healthy volunteers". University de Geneva.

Mr Laurent Barnes, "Effets atrophiques sur la peau des corticostéroïdes topiques", University de Geneva.

Mrs Carolina Sargenti. " Analysis of American Trypanosomiasis world status, outline of evidences and gap

definition: A possible way to harmonization for a better disease management". University de Geneva.

2013

Mrs Fabiana Tirone, "Pharmacovigilance: experience through two phase IV clinical trials" University de Geneva.

Mrs Helena Pontes, "Safety Signal Detection: The relevance of literature review", University de Geneva.

Page 11: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

11

14. PUBLICATIONS

1. ORIGINAL ARTICLES PUBLISHED IN PEER REVIEWED JOURNALS

2016

1. Rollason V, Laverrière A, MacDonald LC, Walsh T, Tramèr MR, Vogt-Ferrier NB. Interventions for

treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).Cochrane Database Syst Rev. 2016

Feb 26;2:CD008455. doi: 10.1002/14651858.CD008455.pub2

2. Vernaz N, Rollason V, Adlere L, Combescure, Poncet A, Bonnabry P, Desmeules J. Snapshot of the

prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the

application guidelines. Pharma Res Per 2016;4(3), e00234.

2015

3. V. Rollason, L. Gschwind, F. Boehlen, M. Rebsamen, C. Combescure, A. Matthey, P. Bonnabry, P.

Dayer, J. A. Desmeules. P-glycoprotein: a clue to vitamin K antagonist stabilization.

Pharmacogenomics 2015;16(2):

2014

4. Girardin F, Poncet A, Blondon M, Vernaz N, Rollason V, Chalandon Y, Dayer P, Combescure C.

Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a

cost-effectiveness analysis. Lancet Psychiatry 2014;1(1):55-62.

5. Marking U, den Boer M, Kumar Das A, Mohammed Ahmed E, Rollason V, Davidson R, Ritmeijer K.

Hypokalaemia induced rhabdomyolysis after treatment of post-kala-azar dermal leishmaniasis (PKDL)

with high dose AmBisome® in Bangladesh – A case report. PLoS Negl Trop Dis. 2014;8(6):e2864.

6. Fonzo-Christe C, Guignard B, Zaugg C, Pfister R, Desmeules J, Rollason V, Posfay Barbe C, Corbelli R,

Gervaix A, Rimensberger P, Bonnabry P. "Impact of clinical decision support guidelines on gentamicin

therapeutic drug monitoring in newborns". Ther Drug Monitor. 2014;15(3):326-43.

2013

7. Gschwind L, Rollason V, Daali Y, Bonnabry P, Dayer P, Desmeules JA. Role of P-glycoprotein in the

uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model.

Basic Clin Pharmacol Toxicol 2013;113(4): 259-65.

8. Gschwind L, Rollason V, Boehlen F, Rebsamen M, Combescure C, Grünenwald M, Matthey A,

Bonnabry P, Dayer P, Desmeules JA. Impact of CYP2C9 polymorphisms on the vulnerability of drug-

drug interactions during acenocoumarol treatment. Pharmacogenomics 2013;14(7):745-53.

9. Gschwind L, Rollason V , Lovis C, Boehlen F, Bonnabry P, Dayer P, Desmeules JA. Identification and

weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care

hospital. Eur J Clin Pharmacol 2013;69(3):617-27.

Page 12: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

12

2. REVIEW ARTICLES PUBLISHED IN PEER REVIEWED JOURNALS

2015

1. Besson M, Samer C, Rollason V, Dayer P, Desmeules J. Providing Quality Therapeutics in Switzerland:

Role of the Stakeholders and Recent Incentives for Further Improvements. Clin Ther. 2015 Jul

1;37(7):1588-92.

2. L. Barnes, G. Kaya, V. Rollason. A systematic review of the skin atrophy induced by topical

corticosteroids: an adverse event that still needs to be clinically assessed. Submitted to Drug Saf (Dec

2014).

2014

3. H. Pontes, M. Clement, V. Rollason. Safety signal detection: the relevance of literature review. Drug

Saf. 2014;37(7):471-9.

4. Rollason V, Samer C, Daali Y, Desmeules J. Prediction by pharmacogenetics of safety and efficacy of

non-steroidal anti-inflammatory drugs: a review. Curr Drug Metab, 2014;15(3):326-43.

2013

5. Samer CF, Rollason V, Ing Lorenzini K, Daali Y, Desmeules JA. Intérêt des outils d’investigation des

enzymes métaboliques en pratique clinique. Douleur Analg, 2013;26:241-7.

6. Rollason V, Samer C, Desmeules J. Pharmacogénétique des anti-inflammatoires non-stéroïdiens.

Douleur Analg 2013;26:195-202.

7. Samer CF, Ing Lorenzini K, Rollason V, Daali Y, Desmeules J. Application of CYP450 testing in the clinical

setting, Mol Diagn Ther 2013;17(3):165-84.

2012

8. Pereira MA, Senhaji S, Rollason V, Jungo NC, Luthy C, Piguet V. Antalgie medicamenteuse et grossesse.

Rev Med Suisse 2012;8(347):1389-92, 1394.

2010

9. Vogt-Ferrier NB, Hugentobler M, Uebelhart B, Tramèr M, Rollason V. Interventions for treating

osteonecrosis of the jaw bones associated with bisphosphonates (Protocol). The Cochrane Library

2010, Issue 4, Chichester: Wiley.

2008

10. Rollason V, Samer C, Piguet V, Dayer P, Desmeules J. Pharmacogenetics of analgesics: toward the

individualization of prescription. Pharmacogenomics. 2008;9:905-33.

Page 13: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

13

2003

11. Desmeules J, Rollason V, Piguet V, Dayer P: Clinical pharmacology and rationale of analgesic

combinations. Eur J Anaesthesiol 2003;20 (28 Suppl): 7-12.

12. Rollason V, Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the

pharmacist. Drugs Aging 2003; 20:817-32.

2001

13. Rollason V, Desmeules J, Vogt N. Effet analgésique des opiacées en usage cutané: quelle est leur

efficacité. Thérapie 2001;56(1):23-27.

3. LETTERS TO THE EDITOR PUBLISHED IN PEER REVIEWED JOURNALS

2016

1. V. Rollason, L. Spahr, M. Escher. Acute severe liver injury due to an artisanal flower pollen preparation

in a patient with high CYP3A4 enzyme activity: a case-report. Eur J Clin Pharmacol. 2016

Apr;72(4):507-8).

2015

2. Rollason V, Desmeules JA. Use of metamizole in children and the risk of agranulocytosis: Is the benefit

worth the risk? Eur J Anaesthesiol. 2015 Dec;32(12):837-8

2012

3. Iancu Ferfoglia R, Rollason Gumprecht V, Villaneau D, Vogt-Ferrier N. A case of pancytopenia with

signs of pulmonary fibrosis and liver cirrhosis secondary to low-dose methotrexate therapy in a patient

with rheumatoid arthritis. European Geriatric Medecine 2012;3:53-6.

2011

4. Rollason Gumprecht V, Schnetzler B, Sunthorn H, Rebsamen M, Desmeules J. Death following "pill-in-

the-pocket" treatment with propafenone and verapamil in a CYP2D6 poor metaboliser. Heart

published online November 4, 2011. Available at: http://heart.bmj.com/content/97/19/1626.1/reply.

4. REVIEW ARTICLES PUBLISHED IN NON PEER REVIEWED JOURNALS

2013

1. Rollason V, Desmeules J. Pharmacogenetics of analgesics for the non-expert. EFIC Refresher

course.8th Congress of the European federation of IASP Chapters (EFIC), Florence, Italy, 2013.

2. Rollason V, Roulet L, Samer C, daali Y, besson M, piguet V, escher M, Dayer P, Desmeules JA. Rotation

of opioids: from theory to practice. SIMPAR 2013, Study in Multidisciplinary Pain Research, 5th

Meeting, Pavia, Italy, In: Minerva Anesthesiologica 2013;79 (Suppl 1 to No 3):10-1.

Page 14: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

14

2004

3. Vogt-Ferrier N, Cabotte E, Moret V, Diet M-C, Déramé L, Jan-Iwaniec F, Schaerer G, Beytrison I,

Ducloux D, Guisado H, Balahoczky M, Rollason V, Pautex S. Constipation: un syndrome gériatrique

mal-aimé. Med Hyg 2004;62:2309-19.

2001

4. Rollason V, Christe C, Vogt N. Problèmes pratiques et éthiques des essais cliniques en gériatrie. Med

Hyg 2001;59:838-42.

5. Prescription médicale d'hydromorphone pour le traitement de la douleur en gériatrie. CAPP-Info,

Bulletin d'information du CAPP (Contact Avis Pharmacologique et Pharmaceutique), No 16, March

2001.

2000

6. Phytothérapie. Pharmaflash, Vol 27, No 3, 2000.

7. Homéopathie. CAPP-Info, Bulletin d'information du CAPP (Contact Avis Pharmacologique et

Pharmaceutique), No 13, July 2000.

8. Liberek C, Desmeules J, Vogt N, Rollason V, Dayer P. Le syndrome sérotoninergique médicamenteux:

un risque à ne pas négliger. Med Hyg 2000;56:834-42.

9. Rollason V, Bonnabry P, Vogt N. Réduire la plurimédication chez la personne âgée: du vœu pieux à des

solutions applicables. Med Hyg 2000;58:818-25.

1999

10. Place des anti-inflammatoires non stéroïdiens topiques en gériatrie. CAPP-Info, Bulletin d'information

du CAPP (Contact Avis Pharmacologique et Pharmaceutique), No 6, October 1999.

5. CHAPTERS IN BOOKS

2010

1. Rollason V, Samer C, Besson M, Piguet V, Daali Y, Dayer P, Desmeules JA. Pharmacogénétique des

analgésiques. In : L’analgésie périopératoire : nouvelles stratégies et perspectives. JEPU 2010.

2009

2. Rollason V, Samer C, Daali Y, Piguet V, Dayer P, Desmeules JA. Chapitre 19 Pharmacogénétique des

analgésiques. In : Douleurs : physiologie, physiopathologie et pharmacologie. Bouhassira D, Calvino B,

editors. Reuil-Malmaison: Arnette Wolters Kluwer France; 2009:291-315.

Page 15: CURRICULUM VITAE · CURRICULUM VITAE 1. PERSONAL DATA Surname: Rollason Name: Victoria Michèle Professional address: Division of Clinical Pharmacology and Toxicology Department of

15

2007

3. Desmeules J, Rollason V, Cedraschi C, Piguet V, Allaz A_F, Dayer P. Chapter 10 Advances in analgesics

and NSAIDs for the treatment of spinal disorders. In: Pain Best Practice and Research Compendium.

Breivik H, Shipley M, editors. Edinburgh: Elsevier, 2007:93-103.

6. ORAL COMMUNICATIONS PRESENTED AT INTERNATIONAL MEETINGS

2014

1. Welle I, Rollason V, Desmeules J, Chopard P. Oral Anticogagulation Quality Control Among Inpatients:

Digging into the Data. ISQUA's 31st

International Conference. Rio de Janeiro, Brésil. October 2014.

2. F. Girardin, A. Poncet, M. Blondon, V. Rollason, N. Vernaz, Y. Chalandon, P. Dayer, C. Combescure.

Cost-effectiveness of monitoring white blood cell count to prevent agranulocytosis in psychotic adults

on clozapine. European and Swiss Congress of Internal Medicine. Geneva, Switzerland. 14-16 May

2014.

2013

3. Rollason V, Gschwind L, Boehlen F, Rebsamen M, Combescure C, Grünenwald M, Matthey A,

Bonnabry P, Dayer P, Desmeules JA. Impact of CYP2C9 polymorphisms on the vulnerability to

pharmacokinetic drug-drug interactions during acenocoumarol treatment. 11th

EACPT Congress 2013,

Geneva, Switzerland. 28-31 August 2013.

2009

4. Zaugg C, Guignard B, Pfister R, Rimensberger P, Rollason V, Desmeules J, Fonzo-Christe C, Bonnabry P.

Gentamicin and vancomycin therapeutic drug monitoring in newborns: evaluation of practices. 38th

European Symposium on Clinical Pharmacy, ESCP - GSASA Symposium, Geneva, Switzerland, 3-6

November 2009.

5. Gschwind L, Rollason Gumprecht V, Boehlen F, Dayer P, Bonnabry P, Desmeules J. Identification and

ponderation of the most critical drug-drug interactions with acenocoumarol, PT-01. 38th European

Symposium on Clinical Pharmacy, ESCP - GSASA Symposium, Geneva, Switzerland, 3-6 November

2009.